Five Prime Therapeutics, Inc.

Report date
3/31/2021
Quarter
2021 Q1
Filed
5/17/2021
Shares
501,618
Value ($000)
18,896
Weight
0.1%
2020 Q4 - 2021 Q1 (2 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).